[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cytosorbents Cor (CTSO)

Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,936
  • Shares Outstanding, K 62,795
  • Annual Sales, $ 37,060 K
  • Annual Income, $ -8,200 K
  • EBIT $ -13 M
  • EBITDA $ -11 M
  • 60-Month Beta 1.43
  • Price/Sales 0.78
  • Price/Cash Flow N/A
  • Price/Book 13.15
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.26
  • Most Recent Earnings $-0.08 on 05/13/26
  • Next Earnings Date 08/06/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Products

Options Overview Details

View History
  • Implied Volatility 470.15% (-393.73%)
  • Historical Volatility 60.88%
  • IV Percentile 68%
  • IV Rank 33.53%
  • IV High 1,215.56% on 12/02/25
  • IV Low 94.16% on 03/16/26
  • Expected Move (DTE 24) 1.8190 (394.75%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 1
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 78
  • Open Int (30-Day) 115
  • Expected Range 0.0000 to 2.2798

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.05
  • Number of Estimates 2
  • High Estimate $-0.04
  • Low Estimate $-0.05
  • Prior Year $-0.05
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4350 +5.93%
on 05/21/26
0.6500 -29.11%
on 04/27/26
-0.1702 (-26.97%)
since 04/22/26
3-Month
0.4350 +5.93%
on 05/21/26
0.8445 -45.44%
on 03/10/26
-0.1794 (-28.02%)
since 02/20/26
52-Week
0.4350 +5.93%
on 05/21/26
1.3900 -66.85%
on 06/24/25
-0.3882 (-45.72%)
since 05/22/25

Most Recent Stories

More News
CytoSorbents: Q1 Earnings Snapshot

CytoSorbents: Q1 Earnings Snapshot

CTSO : 0.4608 (+0.17%)
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update

PRINCETON, N.J. , May 13, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...

CTSO : 0.4608 (+0.17%)
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights

PRINCETON, N.J. , April 30, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...

CTSO : 0.4608 (+0.17%)
CytoSorbents: Q4 Earnings Snapshot

CytoSorbents: Q4 Earnings Snapshot

CTSO : 0.4608 (+0.17%)
CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026

PRINCETON, N.J. , March 19, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...

CTSO : 0.4608 (+0.17%)
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

PRINCETON, N.J. , March 5, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 0.4608 (+0.17%)
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update

Fourth quarter and Full-Year 2025 revenue are expected to be approximately   $9.2 million and $37.0 million, respectively, with expected Q4 gross margins in the range of 73% to 75%

CTSO : 0.4608 (+0.17%)
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025

PRINCETON, N.J. , Dec. 10, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 0.4608 (+0.17%)
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London

PRINCETON, N.J. , Nov. 17, 2025 /PRNewswire/ --  CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 0.4608 (+0.17%)
CytoSorbents: Q3 Earnings Snapshot

CytoSorbents: Q3 Earnings Snapshot

CTSO : 0.4608 (+0.17%)

Business Summary

CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product...

See More

Key Turning Points

3rd Resistance Point 0.4996
2nd Resistance Point 0.4847
1st Resistance Point 0.4727
Last Price 0.4608
1st Support Level 0.4458
2nd Support Level 0.4309
3rd Support Level 0.4189

See More

52-Week High 1.3900
Fibonacci 61.8% 1.0252
Fibonacci 50% 0.9125
Fibonacci 38.2% 0.7998
Last Price 0.4608
52-Week Low 0.4350

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.